THU-245 - Clinically meaningful differences in health-related quality of life and fatigue in patients with hepatitis C virus infection treated with elbasvir/grazoprevir compared to sofosbuvir with pegylated interferon and ribavirin
| Autor: | Nwankwo, C., King-Kallimanis, B., Corman, S., Qiu, J., Patel, S., Arduino, J.M., Platt, H.L., Sperl, J. |
|---|---|
| Zdroj: | In Journal of Hepatology 2017 66(1) Supplement:S297-S298 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect